Clinical Trials Directory

Trials / Terminated

TerminatedNCT01187992

Full-dose Atorvastatin After Acute Coronary Syndrome (ACS) in Non-revascularisable Coronary Artery Disease

Full-dose Atorvastatin Versus Conventional Medical Therapy After Non-ST-elevation Acute Myocardial Infarction in Patients With Advanced Non-revascularisable Coronary Artery Disease

Status
Terminated
Phase
Phase 3
Study type
Interventional
Enrollment
290 (actual)
Sponsor
San Filippo Neri General Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study was designed to test the hypothesis that the addition of full-dose atorvastatin (80 mg/day) to conventional medical treatment could reduce ischaemic recurrences after non-ST-elevation acute myocardial infarction (NSTE-AMI) in patients with severe and diffuse coronary artery disease (CAD) not amenable to any form of mechanical revascularisation.

Conditions

Interventions

TypeNameDescription
DRUGAtorvastatin80 mg/day

Timeline

Start date
2003-09-01
Primary completion
2007-03-01
Completion
2007-04-01
First posted
2010-08-25
Last updated
2010-08-25

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT01187992. Inclusion in this directory is not an endorsement.